Evidence map›Paper›PMID 38076875›Full record

ArticlebioRxiv : the preprint server for biology2023

Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning.

Ruipeng Lei, Enya Qing, Abby Odle, Meng Yuan, Timothy J C Tan, Natalie So, Wenhao O Ouyang, Ian A Wilson, Tom Gallagher, Stanley Perlman and 2 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Ruipeng LeiDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Enya QingDepartment of Microbiology and Immunology, Loyola University Chicago, Maywood, IL 60153, USA.
Abby OdleDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.
Meng YuanDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.ORCID 0000-0001-9754-4503
Timothy J C TanCenter for Biophysics and Quantitative Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0001-5337-5357
Natalie SoDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Wenhao O OuyangDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0002-3618-9808
Ian A WilsonDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Tom GallagherDepartment of Microbiology and Immunology, Loyola University Chicago, Maywood, IL 60153, USA.
Stanley PerlmanDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.
Nicholas C WuDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0002-9078-6697
Lok-Yin Roy WongDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.ORCID 0000-0002-0727-8289
University of Illinois Urbana-Champaign · USLoyola University Chicago · USScripps Research Institute · USUniversity of Iowa · USRutgers, The State University of New Jersey · US

Funding

SARS-CoV Proteins in Heterologous Viral InfectionP01AI060699 · NIAID · UNIVERSITY OF IOWA · PI GALLAGHER, THOMAS MILLER · 2004 to 2021
$21.5M
Role of eicosanoids in pathogenic human CoV infectionsR01AI129269 · NIAID · UNIVERSITY OF IOWA · PI Stanley Perlman · 2016 to 2026
$4.7M
Impacts of Adaptive Coronavirus Evolution on Viral Membrane FusionR21AI178391 · NIAID · LOYOLA UNIVERSITY CHICAGO · PI GALLAGHER, THOMAS MILLER · 2023 to 2024
$437k
Phenotypic and functional characterization of Betacoronavirus Internal protein in relation to virulenceK99AI170996 · NIAID · UNIVERSITY OF IOWA · PI WONG, LOK-YIN ROY · 2022 to 2023
$181k
NIAID NIH HHS K99 AI170996NIAID NIH HHS P01 AI060699NIAID NIH HHS R01 AI129269NIAID NIH HHS R21 AI178391
6 · The paper itself

Abstract

The fusion peptide of SARS-CoV-2 spike protein is functionally important for membrane fusion during virus entry and is part of a broadly neutralizing epitope. However, sequence determinants at the fusion peptide and its adjacent regions for pathogenicity and antigenicity remain elusive. In this study, we performed a series of deep mutational scanning (DMS) experiments on an S2 region spanning the fusion peptide of authentic SARS-CoV-2 in different cell lines and in the presence of broadly neutralizing antibodies. We identified mutations at residue 813 of the spike protein that reduced TMPRSS2-mediated entry with decreased virulence. In addition, we showed that an F823Y mutation, present in bat betacoronavirus HKU9 spike protein, confers resistance to broadly neutralizing antibodies. Our findings provide mechanistic insights into SARS-CoV-2 pathogenicity and also highlight a potential challenge in developing broadly protective S2-based coronavirus vaccines.

Identifiers

PMID38076875
PMCPMC10705381
OpenAlexW4389119356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.